GGrantIndex
Sort

34,240 grants matching atherosclerosis

Lipin-1 transcriptional coregulatory activity promotes macrophage pro-resolving response

$550,760
Matthew Dale Woolard · Louisiana State Univ Hsc Shreveport · R01 · FY2024 · HL

Long term efficacy and safety of orlistat for type 1 hyperlipoproteinemia: a randomized, double-blind, placebo-controlled trial

$550,629
Abhimanyu Garg · Ut Southwestern Medical Center · R61 · FY2023 · HL

Temporal and Spatial Signaling in Chemotaxis

$550,489
Peter N Devreotes · Johns Hopkins University · R01 · FY2006 · GM

Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation

$550,457
Rinad Sary Beidas · Northwestern University At Chicago · R33 · FY2024 · HL

Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c

$550,384
Michael S Brown · Ut Southwestern Medical Center · P01 · FY2013 · HL

Non-Invasive Approaches to Assessing Inflammation (RMI)

$550,362
Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P20 · FY2006 · RR

ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5

$550,298
Lynne E Wagenknecht · Wake Forest University Health Sciences · U01 · FY2018 · HL

Fractalkine: Roles in Cell Adhesion and Atherosclerosis

$550,280
Israel F. Charo · J. David Gladstone Institutes · R01 · FY2007 · HL

Determinants of Coronary Atherosclerotic Plaque Progression/Regression

$550,231
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P50 · FY2008 · HL

EPIDEMIOLOGY OF CAROTID ARTERY ATHEROSCLEROSIS IN YOUTH

$550,164
University Of Iowa · R01 · FY2002 · HL

CaMKII/MK2 Signaling in Cardiometabolic Disease

$550,142
Ira A Tabas · Columbia University Health Sciences · P01 · FY2021 · HL

CaMKII/MK2 Signaling in Cardiometabolic Disease

$550,142
Ira A Tabas · Columbia University Health Sciences · P01 · FY2020 · HL

CaMKII/MK2 Signaling in Cardiometabolic Disease

$550,142
Ira A Tabas · Columbia University Health Sciences · P01 · FY2022 · HL

CaMKII/MK2 Signaling in Cardiometabolic Disease

$550,142
Ira A Tabas · Columbia University Health Sciences · P01 · FY2019 · HL

T-cell subsets as CVD risk factors in CHS and MESA

$550,131
Bruce M Psaty · University Of Washington · R01 · FY2017 · HL

Three-dimensional maps of senescence in the human pancreas

$550,000
Pei-Hsun Wu · Johns Hopkins University · UG3 · FY2023 · CA

Three-dimensional maps of senescence in the human pancreas

$550,000
Pei-Hsun Wu · Johns Hopkins University · UG3 · FY2022 · CA

Aging Effects on Cardiovascular Function

$549,995
Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2004 · AG

Cellular Mechanics and Microvascular Interactions

$549,976
Richard E Waugh · University Of Rochester · P01 · FY2012 · HL

Mechanisms of HCMV-induced monocyte-to-macrophage differentiation.

$549,860
Gary Ching Tao Chan · Upstate Medical University · R01 · FY2020 · AI

Transcriptional regulation of arteriovenous differentiation

$549,793
William T Pu · Boston Children'S Hospital · R01 · FY2018 · HL

Transcriptional regulation of arteriovenous differentiation

$549,793
William T Pu · Boston Children'S Hospital · R01 · FY2019 · HL

Transcriptional regulation of arteriovenous differentiation

$549,793
William T Pu · Boston Children'S Hospital · R01 · FY2020 · HL

Genetic Epidemiology of Body Mass Index, Adiposity and Weight Gain

$549,785
Karen L Mohlke · Univ Of North Carolina Chapel Hill · R01 · FY2008 · DK

Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse

$549,652
Karl-Dimiter Bissig · Duke University · R01 · FY2020 · HL